Chronic Kidney DiseaseModifications to Objectives and Subobjectives Progress Toward Healthy People 2010 Targets Progress Toward Elimination of Health Disparities Disparities Table (See below) References |
 |
|
References
1U.S. Renal Data System. USRDS 2005 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005.
2Peralta, C.A., et al. The metabolic syndrome and chronic kidney disease. Current Opinion in Nephrology and Hypertension 15(4):361–365, 2006.
3Coppo, R., et al. Predictors of outcome in Henoch-Schonlein nephritis in children and adults. American Journal of Kidney Disease 47(6):993–1003, 2006.
4Osawa, H., et al. Losartan, an angiotensin-II receptor antagonist, retards the progression of advanced renal insufficiency. Tohoku Journal of Experimental Medicine 209(1):7–13, 2006.
5Weinberg, A.J., et al. Long-term safety of high-dose angiotensin receptor blocker therapy in hypertensive patients with chronic kidney disease. Journal of Hypertension 24(Suppl 1):S95–S99, 2006.
6Ravera, M., et al. Importance of blood pressure control in chronic kidney disease. Journal of the American Society of Nephrology 17(4 Suppl 2):S98–S103, 2006.
7Barnett, A. Prevention of loss of renal function over time in patients with diabetic nephropathy. Review. American Journal of Medicine 119(5 Suppl 1):S40–S47, 2006.
8Ishimitsu, T., et al. Effects of valsartan on the progression of chronic renal insufficiency in patients with nondiabetic renal diseases. Hypertension Research 28(11):865–870, 2005.
9Nakayama, Y., et al. Long-term renoprotective effect of combination therapy with prostaglandin E1 and angiotensin-converting enzyme inhibitor in patients with chronic renal failure. Hypertension Research 28(9):733–739, 2005.
10More information available at www.kidney.org/Professionals/kdoqi/, www.diabetes.org/for-health-professionals-and-scientists/cpr.jsp, www.ndep.nih.gov/diabetes/prev/prevention.htm, and www.nkdep.nih.gov/; accessed October 31, 2006.
11Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 346(6):393–403, 2002.
12More information available at http://ndep.nih.gov/campaigns/campaigns.htm; accessed October 31, 2006.
13Venkataraman, R., et al. Outcomes in patients with chronic kidney disease undergoing cardiac rehabilitation. American Heart Journal 150(6):1140–1146, 2005.
14Painter, P. Physical functioning in end-stage renal disease patients: Update 2005. Review. Hemodialysis International 9(3):218–235, 2005.
15Stack, A.G., et al. Association of physical activity with mortality in the U.S. dialysis population. American Journal of Kidney Disease 45(4):690–701, 2005.
16Gibson, K.D., et al. Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the U.S. Renal Data System Dialysis Morbidity and Mortality Study. Journal of Vascular Surgery 34(4):694–700, 2001.
17Hemphill, H., et al. How can the use of arteriovenous fistulas be increased?—A series of opinion papers. Seminars in Dialysis 16(3):214–223, May–June 2003.
18More information available at www.usrds.org/atlas.htm, www.kidney.org/Professionals/kdoqi/, www.diabetes.org/for-health-professionals-and-scientists/cpr.jsp, www.ndep.nih.gov/diabetes/prev/prevention.htm, and www.nkdep.nih.gov/; accessed October 31, 2006.
19Cecka, J.M., et al. Could more effective use of kidneys recovered from older deceased donors result in more kidney transplants for older patients? Transplantation 81(7):966–970, 2006.
20Friedman, E.A., and Friedman, A.L. Payment for donor kidneys: Pros and cons. Review. Kidney International 69(6):960–962, 2006.
21Mokdad, A.H., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association 289(1):76–79, 2003.
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.
<< Previous—Objectives and Subobjectives | Table of Contents | Next—Related Objectives From Other Focus Areas >>